Why the study?
Are angiotensinogen gene variants M235T and T174M associated with an increased risk of coronary heart disease or hypertension in the Indian population?
Are angiotensinogen gene variants M235T and T174M associated with an increased risk of coronary heart disease or hypertension in the Indian population?
Answers are grounded in this paper and cite their sources.
The M235T and T174M variants of the angiotensinogen gene do not contribute to an increased risk of coronary heart disease or hypertension in the Indian population.
Gene encoding components of the renin angiotensin system (RAS) have been implicated with the increased risk of cardiovascular disease (CVD). Two variants of the angiotensinogen (AGT) gene, M235T and T174M, have been shown to be associated with increased risk of hypertension. In the present study, we examined the association of these two polymorphisms and their synergistic interaction with the angiotensin I-converting enzyme (ACE) deletion homozygote genotype (D/D) on subjects with coronary heart disease (CHD) and hypertension. We studied 131 healthy individuals, 141 angiographically verified CHD patients, and 159 hypertensive subjects. The identification of the ACE and AGT gene polymorphisms was carried out using a PCR-based restriction endonuclease digestion method. There was no significant difference in the distribution of the M235T and T174M variants between the two test groups and the control group. Association was also not seen when analysis was carried out in patients when subgrouped according to the extent of the severity of the disease. In addition, the risk was not restricted to subjects carrying the D allele of the ACE gene and T235T of AGT. M235T and T174M variants do not contribute to the increased risk of CHD or hypertension in the Indian population.
No takes yet. Share an insight, caveat, or question.
Nair et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: